WuXi to build manufacturing facility in U.S.

By The Science Advisory Board staff writers

May 19, 2020 -- WuXi Biologics announced it has signed a deal with Worcester Business Development to build a clinical and commercial manufacturing facility in Worcester, MA.

The 107,000-sq-ft facility is expected to be completed in 2022. The location is the first U.S. biomanufacturing facility for WuXi. According to the company, the campus will be located on a 46-acre plot and will create 150 new jobs for the local economy.

WuXi is a Hong-Kong based drug discovery and clinical and commercial manufacturing organization. It currently has over 100 projects in phase I and II clinical development and 16 in phase III development, as well as one project in commercial manufacturing.


Copyright © 2020 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?